Jude Onyia

Chief Tech/Sci/R&D Officer presso NEUROCRINE BIOSCIENCES, INC.

Patrimonio netto: 2 M $ in data 31/03/2024

60 anni

Health Technology

Consumer Services

Commercial Services

Posizioni attive di Jude Onyia

Società	Posizione	Inizio	Fine
NEUROCRINE BIOSCIENCES, INC.	Chief Tech/Sci/R&D Officer	30/11/2021	-
VOYAGER THERAPEUTICS, INC.	Director/Board Member	21/02/2023	-

Società	Posizione	Inizio	Fine
Capsida Biotherapeutics, Inc. Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA.	Chief Tech/Sci/R&D Officer	01/06/2021	01/11/2021
ELI LILLY AND COMPANY	Corporate Officer/Principal	01/09/2014	01/06/2021

The State University of New York	Undergraduate Degree
State University of New York at Downstate Medical Center	Doctorate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Chief Tech/Sci/R&D Officer	2
Undergraduate Degree	1
Corporate Officer/Principal	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	1
Capsida Biotherapeutics, Inc. Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA.	Commercial Services